What is Dianthus Therapeutics's free cash flow margin?

Dianthus Therapeutics (DNTH) reported free cash flow margin of -3,561.6% in Q3 2025.

How has Dianthus Therapeutics's free cash flow margin changed year-over-year?

Dianthus Therapeutics's free cash flow margin decreased by 204.9% year-over-year, from -1,168% to -3,561.6%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Dianthus Therapeutics DNTH Free cash flow margin

Free cash flow margin at other companies

Johnson & JohnsonJNJ

18.5%-4.3pp

AmgenAMGN

23.1%-8.9pp

Kymera TherapeuticsKYMR

-474%+92.4pp

BiogenBIIB

24.4%-0.4pp

Regeneron PharmaceuticalsREGN

27.6%+5.5pp

BridgeBio PharmaBBIO

-76.8%—

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Enterprise value$3.88B+565%

P/S1,465.1×+962×

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Calculated from Dianthus Therapeutics’s reported figures.

free cash flow/total revenue=-3,561.6%

Based on trailing twelve months.

The official record: Dianthus Therapeutics’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's free cash flow margin?: Dianthus Therapeutics (DNTH) reported free cash flow margin of -3,561.6% in Q3 2025.
How has Dianthus Therapeutics's free cash flow margin changed year-over-year?: Dianthus Therapeutics's free cash flow margin decreased by 204.9% year-over-year, from -1,168% to -3,561.6%.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.